HCCs of G2 have a high copy number of HBV and mutations in PIK3CA and TP53. Furthermore, activation of the PI3K-Akt pathway is prominent in both G1 and G2 HCC tumors. This evidence concerns the gene AKT1 and hepatocellular carcinoma.